I think we should find more announcements in the next two months, and then 1st quarter of 2018. So would expect some sort of approvals, and then sales to follow through based on approvals and on the manufacturing plant that they have with the people staffed and machinery in place.
MVP CEO Mr. John Sharman said: "We are delighted with the confidence shown in MVP by the global investment community. MVP is gaining momentum in terms of its ambition to become a global pharmaceutical and medical device company. We have a number of milestone events which we hope to deliver during the latter part of this year and during the first quarter of 2018. We hope the achievement of these milestones will be reflected in the value of our company in the future."
Ann: Penthrox approved in Mexico, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.0¢ | 45.0¢ | $35.81K | 79.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35858 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 28479 | 4 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |